01 1Ajinomoto OmniChem N.V.
02 1Aurobindo Pharma Limited
03 1Chromo Laboratories India Private Limited
04 1Glaxo Wellcome Manufacturing Pte. Ltd
05 1HETERO LABS LIMITED
06 1Hetero Labs Limited
07 1Honour Lab Limited
08 1MSN Life Sciences Private Limited
09 1Shanghai Desano Chemical Pharmaceutical Co., Ltd.
10 1Shionogi Pharma Co., Ltd.
11 2Tianish Laboratories Private Limited
12 1Viyash Life Sciences Private Limited
01 2DOLUTEGRAVIR SODIUM
02 1DOLUTEGRAVIR SODIUM IH
03 1Dolutegravir
04 6Dolutegravir Sodium
05 1Dolutegravir sodium
06 1Micronized Dolutegravir Sodium
07 1dolutegravir sodium
01 1Belgium
02 1China
03 9India
04 1Japan
05 1United Kingdom
NDC Package Code : 50923-0116
Start Marketing Date : 2016-02-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-962
Start Marketing Date : 2023-11-02
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52562-012
Start Marketing Date : 2021-12-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52482-016
Start Marketing Date : 2018-02-19
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0093
Start Marketing Date : 2013-08-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0135
Start Marketing Date : 2016-06-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69037-0044
Start Marketing Date : 2016-06-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69766-023
Start Marketing Date : 2016-12-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42931-242
Start Marketing Date : 2021-09-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53044-001
Start Marketing Date : 2016-06-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Dolutegravir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dolutegravir, including repackagers and relabelers. The FDA regulates Dolutegravir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dolutegravir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dolutegravir manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dolutegravir supplier is an individual or a company that provides Dolutegravir active pharmaceutical ingredient (API) or Dolutegravir finished formulations upon request. The Dolutegravir suppliers may include Dolutegravir API manufacturers, exporters, distributors and traders.
click here to find a list of Dolutegravir suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dolutegravir as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dolutegravir API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dolutegravir as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dolutegravir and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dolutegravir NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dolutegravir suppliers with NDC on PharmaCompass.
We have 11 companies offering Dolutegravir
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
